| Code | 27959 | ||||||||||
| MA number | 14/0144/15-S | ||||||||||
| Product Form: | plv inh 1x60 dávok (blis.+inhalátor) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | GlaxoSmithKline Trading Services Limited, Ireland | ||||||||||
| Therapeutic Class: | 14 - BRONCHODILATANTIA, ANTIASTHMATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 18 | ||||||||||
| Container: | blister PVC/Aclar/PCTFE | ||||||||||
| Route of admin.: | Inhalation use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 21.04.1998 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Flixotide Diskus 250 µg_01/2021.doc.doc
|
| SPC: |
SPC_Flixotide Diskus 250 µg_01/2021.doc.docx
|
| Safety feature | Yes |
| Data update: | 15.05.2018 |
